Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 1
1985 1
1986 1
1987 4
1989 1
1990 1
1992 1
1994 2
1995 1
1998 1
1999 3
2000 2
2001 2
2002 3
2003 1
2004 1
2005 3
2006 3
2007 1
2008 1
2009 2
2010 4
2011 3
2012 4
2013 7
2014 6
2015 4
2016 4
2017 6
2018 8
2019 11
2020 6
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18431444

101 results

Results by year

Filters applied: . Clear all
Page 1
Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A, Laiskonis A, Balciuniene L, Banzhoff A, Malerczyk C. Ambrozaitis A, et al. Vaccine. 2006 May 8;24(19):4116-21. doi: 10.1016/j.vaccine.2006.02.036. Epub 2006 Feb 28. Vaccine. 2006. PMID: 16545510 Clinical Trial.
Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
Quiambao BP, Ambas C, Diego S, Bosch Castells V, Korejwo J, Petit C, Houillon G. Quiambao BP, et al. Vaccine. 2019 Apr 10;37(16):2268-2277. doi: 10.1016/j.vaccine.2019.02.083. Epub 2019 Mar 16. Vaccine. 2019. PMID: 30890382 Free article. Clinical Trial.
Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
Kerdpanich P, Chanthavanich P, De Los Reyes MR, Lim J, Yu D, Ama MC, Mojares Z, Casula D, Arora AK, Pellegrini M. Kerdpanich P, et al. PLoS Negl Trop Dis. 2018 Jun 6;12(6):e0006340. doi: 10.1371/journal.pntd.0006340. eCollection 2018 Jun. PLoS Negl Trop Dis. 2018. PMID: 29874228 Free PMC article. Clinical Trial.
One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety.
Quiambao BP, Lim JG, Bosch Castells V, Augard C, Petit C, Bravo C, Delore V, Houillon G. Quiambao BP, et al. Vaccine. 2022 Aug 26;40(36):5347-5355. doi: 10.1016/j.vaccine.2022.07.037. Epub 2022 Aug 3. Vaccine. 2022. PMID: 35933278 Free article. Clinical Trial.
Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
Sudarshan MK, Narayana DH, Madhusudana SN, Holla R, Ashwin BY, Gangaboraiah B, Ravish HS. Sudarshan MK, et al. Hum Vaccin Immunother. 2012 Aug;8(8):1077-81. doi: 10.4161/hv.20471. Epub 2012 Aug 1. Hum Vaccin Immunother. 2012. PMID: 22699446 Free PMC article. Clinical Trial.
101 results